US sterile processing supplies firm Key Surgical has merged with European rival Interlock to create a global organization. The deal follows on Interlock’s acquisition last year of UK company Clinipak. Financial terms of the deal were not disclosed.
US company Key Surgical has merged with its German rival, Interlock, to form a global sterile processing organization. The deal follows on from Interlock's acquisition last year of UK company Clinipak. Healthcare investor, Water Street Healthcare Partners, led the merger of the businesses. Financial terms of the deal were not disclosed.
Key Surgical president and chief operating officer Brian O'Connell told Medtech Insight the merger positions the company as a global...
European venture capital firm Sofinnova Partners’ portfolio companies BioCorteX, Bioptimus, Cure51 and Latent Labs will benefit from the investor’s new partnership with tech giant NVIDIA.
Roche aims to grow its diagnostics sales by mid to high single digits, said CEO of Roche Diagnostics Matt Sause. The company unveiled the Axelios synthesis and sequencing solution and discussed its “long-term commitment” to China, as well as its business strategy for the next five years.
The consumer genomics firm will operate as a subsidiary, while Regeneron plans to leverage its database for drug discovery and trial design efforts.
An interactive look at medtech and diagnostics deals made during March 2025. Data courtesy of Biomedtracker.
